Rapamycin inhibits vascular smooth muscle cell migration.

Abnormal vascular smooth muscle cell (SMC) proliferation and migration contribute to the development of restenosis after percutaneous transluminal coronary angioplasty and accelerated arteriopathy after cardiac transplantation. Previously, we reported that the macrolide antibiotic rapamycin, but not...

Descrición completa

Detalles Bibliográficos

Publicado en:	J Clin Invest
Principais autores:	Poon, M, Marx, S O, Gallo, R, Badimon, J J, Taubman, M B, Marks, A R
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Clinical Investigation 1996
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC507677/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8941644/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI119038
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!